에서 실시간으로 운영 중이에요!
자세히 알아보기
WWB
Windward Bio Group
WWB
WWB
소개: Windward Bio Group AG is a clinical-stage biotechnology company developing ultra-long-acting antibody medicines for patients with serious respiratory and dermatologic diseases, including asthma, COPD, and atopic dermatitis. Its flagship program is WIN378, a potentially novel, long-acting, anti-TSLP monoclonal antibody. The pipeline also includes WIN027, a clinical-stage, long-acting anti-TSLPxIL-13 bi-specific, which has therapeutic application across immunological diseases.
뉴스
긍정적
중립
부정적
투자 심리
3개월
긍정적
0%
중립
0%
부정적
0%
WWB에 대한 최신 뉴스 기사를 아직 받지 못했어요.
Lightweight Charts™를 사용해 가격 차트를 구현했어요.